| ADR Ontology |
| ADR Term |
Macroamylasaemia |
| ADR ID |
BADD_A07381 |
| ADR Hierarchy |
|
| Description |
A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes. | A benign condition in which the circulating AMYLASES are of high molecular masses, macroamylases. Macroamylases are amylase-plasma protein complexes, usually with immunoglobulins. Macroamylases cannot be cleared by the renal glomeruli. [MeSH] |
| MedDRA Code |
10025376 |
| MeSH ID |
D034321
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Macroamylasaemia | Macroamylasemia | Hyperamylasemia |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01566 | Nifedipine | 0.000075% | |
| The 1th Page 1
Total 1 Pages
|
|
